Dimerol-MR 30: Gliclazide 30mg Tablet.
This medication is recommended in adults for non-insulindependent diabetes (type-II), in association with dietary measures and with physical exercise, when these measures alone are not sufficient to obtain normal blood glucose levels.
Dimerol-MR 30: Gliclazide 30mg Tablet.
This medication is recommended in adults for non-insulindependent diabetes (type-II), in association with dietary measures and with physical exercise, when these measures alone are not sufficient to obtain normal blood glucose levels.
Drug International Limited was incorporated under the Registrar of Joint Stock Companies in 1974 as a Private Limited Company. The company commenced formulation and production in 1983 and emerged as a pioneer in Bangladesh for adding a state of the art oral solid dosage plant. Since inception, Drug International Limited's primary objective has been to meet guidelines provided by major global regulatory bodies such as the World Health Organization Good Manufacturing Practices (WHO cGMP) guidelines.